Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE study.

The World Allergy Organization journal·2026
Same author

Patch Test Results With Additions to the European Baseline Series, 2021/22-Joint European Results of the ESSCA<sup>A</sup> and the EBS<sup>B</sup> Working Groups of the ESCD, and the GEIDAC<sup>C</sup>.

Contact dermatitis·2026
Same author

Association Between Thumb Hypoplasia, Radial Longitudinal Deficiency, and Radial Polydactyly.

The Journal of hand surgery·2026
Same author

[Therapeutic options for occupational skin cancer (BK 5102, BK 5103)].

Dermatologie (Heidelberg, Germany)·2026
Same author

S2k guideline occupational skin products: skin protection creams, skin cleansing and skin care products.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

A HRH1-YAP1 feedback loop drives pancreatic cancer progression and predicts therapeutic response.

Oncology letters·2026
Same journal

Application and challenges of chimeric antigen receptor T cell therapy in the treatment of acute myeloid leukemia (Review).

Oncology letters·2026
Same journal

Prognostic value of the preoperative lactate dehydrogenase-to-albumin ratio in patients with gastrointestinal cancer.

Oncology letters·2026
Same journal

Erratum: [Corrigendum] Wentilactone A induces cell apoptosis by targeting AKR1C1 gene via the IGF-1R/IRS1/PI3K/AKT/Nrf2/FLIP/Caspase-3 signaling pathway in small cell lung cancer.

Oncology letters·2026
Same journal

Erratum: [Corrigendum] Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer.

Oncology letters·2026
Same journal

Erratum: [Corrigendum] Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population.

Oncology letters·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Erratum: [Corrigendum] Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro.

Lysann Michaela Kroschwald, Josephine Tabea Tauer, Sonja Ingrid Kroschwald

    Oncology Letters
    |June 22, 2026
    PubMed
    Summary
    This summary is machine-generated.

    This study corrects a previously published article's DOI. The correction ensures accurate citation and retrieval of scientific research on the topic.

    Area of Science:

    • This study falls within the scope of molecular biology and scientific publishing standards.

    More Related Videos

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
    13:22

    Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

    Published on: October 23, 2019

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013